Related Experiment Video
Updated: Apr 18, 2026

Oxygen-Glucose Deprivation and Reoxygenation as an In Vitro Ischemia-Reperfusion Injury Model for Studying Blood-Brain Barrier Dysfunction
Published on: May 7, 2015
Neuroprotective mechanisms of oxygen and ethanol: a potential combination therapy in stroke
Sweena Parmar, Shannon Moore-Langston, Vance Fredrickson
1Department of Neurological Surgery, Wayne State University School of Medicine, 550 E Canfield, Detroit, MI 48201, USA. yding@med.wayne.edu.
Abstract:
Currently, stroke researchers are racing to develop neuroprotective strategies that shield the brain from ischemia-induced injury. To date, neuroprotective agents that have shown promise in animal studies have failed in clinical trials. Since the pathophysiology of ischemic stroke exploits numerous pathways leading to cellular injury, a combination of neuroprotective agents may offer substantially better results than a single agent alone - by intervening in multiple mechanisms. In this paper, we consider an approach using combination therapy with normobaric oxygen (NBO) and ethanol. Studies indicate that NBO therapy improves tissue oxygenation, thereby reducing the extent of hypoxic injury and decelerating the development of tissue necrosis when administered early after stroke onset. Studies have also demonstrated that low to moderate levels of ethanol not only decrease the risk of stroke, but also reduce post-ischemic sequelae. This article reviews the history of NBO and ethanol therapies, their mechanisms of action, the results of key clinical trials, and the rationale for their use as a combination therapy in the context of stroke treatment.
Insights
This study explores combining normobaric oxygen (NBO) and ethanol for stroke treatment. This combination therapy may offer better neuroprotection against ischemic injury than single agents by targeting multiple pathways.
Area of Science:
- Neuroscience
- Pharmacology
- Emergency Medicine
Background:
- Stroke research faces challenges with neuroprotective agents failing in clinical trials.
- Ischemic stroke involves multiple injury pathways, suggesting combination therapy may be more effective.
- Existing single-agent neuroprotective strategies have limited clinical success.
Purpose of the Study:
- To review the potential of combining normobaric oxygen (NBO) and ethanol as a neuroprotective stroke therapy.
- To evaluate the historical use, mechanisms, and clinical trial data for NBO and ethanol in stroke.
- To establish the rationale for using NBO and ethanol in combination for stroke treatment.
Main Methods:
- Literature review of normobaric oxygen (NBO) therapy in stroke.
- Literature review of ethanol therapy in stroke.
- Analysis of existing clinical trial data for NBO and ethanol.
- Synthesis of evidence supporting combination therapy.
Main Results:
- Normobaric oxygen (NBO) therapy enhances tissue oxygenation, reducing hypoxic injury and necrosis post-stroke.
- Low to moderate ethanol levels are associated with reduced stroke risk and improved post-ischemic outcomes.
- Evidence suggests NBO and ethanol target distinct but complementary pathways in ischemic stroke.
Conclusions:
- Combination therapy with normobaric oxygen (NBO) and ethanol presents a promising neuroprotective strategy for stroke.
- This combined approach may overcome limitations of single-agent therapies by addressing multiple injury mechanisms.
- Further investigation into the clinical application of NBO and ethanol combination therapy is warranted.
More Related Videos
09:48Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice
Published on: May 4, 2015
07:34Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research
Published on: December 15, 2023
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology